Právní předpis byl sestaven k datu 01.08.2023.
Zobrazené znění právního předpisu je účinné od 01.08.2023 do 05.03.2024.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
č. 46/2017 Sb. - Čl. II
č. 30/2018 Sb. - Čl. II
č. 242/2018 Sb. - Čl. II
č. 194/2021 Sb. - Čl. II
č. 159/2022 Sb. - Čl. II
č. 228/2023 Sb. - Čl. II
463
XXXXXXXX XXXXX
xx dne 18. prosince 2013
x xxxxxxxxx xxxxxxxxxx xxxxx
Xxxxx xxxxxxxx xxxxx §44c xxxx. 1 xxxxxx x. 167/1998 Sb., x xxxxxxxxxx látkách x o xxxxx xxxxxxxxx xxxxxxx xxxxxx, xx xxxxx xxxxxx x. 273/2013 Sb.:
§1
Xxxx xxxxxxxx stanoví
a) x příloze č. 1 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx X xxxxx Xxxxxxxx xxxxxx x omamných látkách1) x
2. xxxxxxx omamných xxxxx, s xxxxx xx x xxxxxx xxxxxxx jejich zneužívání xxxxx proto, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx zdraví, nezbytné xxxxxxx xxxxxxxxx xxx xx xxxxxxx povolení x xxxxxxxxx, nebo xx z tohoto xxxxxx xxxxx xxxxxxxxxx, xxx xxxxxx přípravky xxxxxxxxxx tyto omamné xxxxx xxxx vydávány x xxxxxxx pouze xx xxxxxx nebo xxxxxxx označené xxxxxx xxxxxx směřujícím z xxxxxx xxxxxxx xxxx xx xxxxxxx xxxxxxx xxxx,
(xxxx xxx "xxxxxx x. 1 xxxxxxxx xxxxx"),
x) x příloze č. 2 x tomuto nařízení xxxxxx
1. omamných látek xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx x
2. xxxxxxx xxxxxxxx xxxxx, u xxxxx xx x xxxxxx xxxxxxx jejich xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx zdraví, xxxxx zabezpečit, xxx xxxxxx přípravky obsahující xxxx xxxxxx látky xxxx xxxxxxxx x xxxxxxx na xxxxxx xxxx xxxxxxx xxx xxxxxxxx modrým xxxxxx,
(xxxx xxx "seznam x. 2 xxxxxxxx látek"),
c) x příloze č. 3 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx látek zařazených xx Xxxxxxx IV xxxxx Xxxxxxxx xxxxxx x xxxxxxxx látkách x
2. xxxxxxx xxxxxxxx xxxxx, u xxxxx xx z xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, že xxxxxxxxxxxxx nebo xxxxxxx xxxxxxxx xxxxxx, nutné xxxxxxxxxx, aby xxxxx x přípravky xxxxxxxxxx xxxx xxxxxx xxxxx xxxx xxxxxxxxx pouze x omezeným xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx xxxxxxxxxxxxx účelům xxxxxxxxx x xxxxxxxx x xxxxxxxxx,
(xxxx xxx "xxxxxx x. 3 xxxxxxxx xxxxx"),
x) x příloze č. 4 k xxxxxx xxxxxxxx seznam
1. psychotropních xxxxx zařazených xx Xxxxxxx X podle Xxxxxx x xxxxxxxxxxxxxx xxxxxxx2) x
2. xxxxxxx xxxxxxxxxxxxxx látek, x xxxxx xx x xxxxxx rozsahu jejich xxxxxxxxxx xxxxx xxxxx, xx bezprostředně xxxx xxxxxxx ohrožují xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxx a xxxxxxxxx xxxxxxxxxx tyto psychotropní xxxxx xxxx xxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxx x xxxxxxxx x xxxxxxxxx,
(xxxx xxx "xxxxxx č. 4 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 5 x xxxxxx xxxxxxxx seznam
1. xxxxxxxxxxxxxx látek xxxxxxxxxx xx Xxxxxxx II xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx a
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, x xxxxx xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx anebo xxxxx, že bezprostředně xxxx xxxxxxx xxxxxxxx xxxxxx, nezbytné xxxxxxx xxxxxxxxx xxx xx xxxxxxx xxxxxxxx x xxxxxxxxx, nebo xx x xxxxxx důvodu xxxxx xxxxxxxxxx, xxx xxxxxx přípravky xxxxxxxxxx xxxx psychotropní xxxxx xxxx xxxxxxxx x xxxxxxx xxxxx xx xxxxxx nebo xxxxxxx xxxxxxxx modrým xxxxxx xxxxxxxxxx x xxxxxx xxxxxxx xxxx do xxxxxxx xxxxxxx xxxx,
(xxxx xxx "xxxxxx x. 5 xxxxxxxxxxxxxx látek"),
f) x příloze č. 6 x xxxxxx xxxxxxxx seznam xxxxxxxxxxxxxx látek xxxxxxxxxx xx Xxxxxxx III xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx,
x) v příloze č. 7 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx do Xxxxxxx IV xxxxx Xxxxxx o xxxxxxxxxxxxxx xxxxxxx a
2. dalších xxxxxxxxxxxxxx xxxxx, u xxxxx je z xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx proto, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx zabezpečit, aby xxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxx xxxx xxxxxxxx v xxxxxxx xx xxxxxx xxxx xxxxxxx xxx označení xxxxxx xxxxxx,
(xxxx xxx "xxxxxx č. 7 xxxxxxxxxxxxxx xxxxx"), x
x) x příloze č. 8 k xxxxxx xxxxxxxx xxxxxx xxxxxxxxx xxxxxxxxxx do Xxxxxxx XXX xxxxx Xxxxxxxx xxxxxx o xxxxxxxx látkách,
(dále xxx "xxxxxx č. 8 xxxxxxxxx xxxxxxxxx").
§2
(1) Xxxx nařízení xxxx oznámeno x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx 98/34/ES ze xxx 22. června 1998 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x oblasti xxxxx x xxxxxxxxxxx předpisů x předpisů xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx, x xxxxxxx xxxxx.
(2) Xxxx xxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx Evropské xxxx xxxxxxxx xx xxxxxxxxxx xxxxx3).
§3
Toto nařízení xxxxxx xxxxxxxxx xxxx 1. xxxxx 2014.
Xxxxxxx č. 1 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 1 omamných xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx |
Chemický název xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(5X,6X,7X)-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-4,5-xxxxx-6,14-xxxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxx-xxxx-xxxxxxxxxxxxxx |
(XX)-X-[1-(2-xxxxx-2-xxxxxxxxxxx)-4-xxxxxxxx]xxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
(3XX)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxx-xxxxxxxxxxxxxx |
X-{1-[(1XX)-2-xxxxx-1-xxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxx |
X-{1-[(1XX)-1-xxxxxx-2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxx piperidin-4-yl-propanoát |
|
|
Alfentanil |
N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl}-N-fenylpropanamid |
|
|
Allylprodin |
3-allyl-4-fenyl-1-methylpiperidin-4-yl-propanoát |
|
|
Anileridin |
ethyl-1-(4-aminofenethyl)-4-fenylpiperidin-4-karboxylát |
|
|
Benzethidin |
ethyl-1-[2-(benzyloxy)ethyl]-4-fenylpiperidin-4-karboxylát |
|
|
Benzylmorfin |
3-(benzyloxy)-4,5α-epoxy-17-methylmorfin-7-en-6α-ol |
|
|
Betacetylmethadol |
(3S,6R)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát |
|
|
Beta-hydroxyfentanyl |
N-{1-[(2RS)-2-hydroxyfenethyl]piperidin-4-yl}propananilid |
|
|
Beta-hydroxymethylfentanyl |
N-{1-[(2RS)-2-hydroxyfenethyl]-3-methylpiperidin-4-yl}propananilid |
|
|
Betameprodin |
(3RS,4RS)-3-ethyl-4-fenyl-1-methylpiperidin-4-yl-propanoát |
|
|
Betamethadol |
(3S,6R)-6-(dimethylamino)-4,4-difenylheptan-3-ol |
|
|
Betaprodin |
(3RS,4RS)-4-fenyl-1,3-dimethylpiperidin-4-yl-propanoát |
|
|
Bezitramid |
2,2-difenyl-4-[4-(2-oxo-3-propanoyl-2,3-dihydro-1H-benzimidazol-1-yl)piperidino]butannitril |
|
|
Dextromoramid |
1-[(3S)-2,2-difenyl-3-methyl-4-morfolinobutanoyl]pyrrolidin |
|
|
Diampromid |
N-[2-(N-fenethyl-N-methylamino)propyl]propananilid |
|
|
Diethylthiambuten |
3-(diethylamino)-1,1-di(2-thienyl)but-1-en |
|
|
Difenoxin |
1-(3,3-difenyl-3-kyanpropyl)-4-fenylpiperidin-4-karboxylová xxxxxxxx |
|
|
Xxxxxxxxxxx |
xxxxx-1-(3,3-xxxxxxx-3-xxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
(5X,6X,7X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx |
|
|
Xxxxxxxxxxx |
[2-(xxxxxxxxxxxxx)xxxxx]-2-xxxxxx-2,2-xxxxxxx-xxxxxx |
|
|
Xxxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxx-xxxxxxx |
xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
(6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx |
|
|
Xxxxxxx |
xxxxxxxx (x.X.2X,3X5X)3-xxxxxxx-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxxx, její xxxxxx x xxxxxxxx, x xxxxxxx je xxxxx xxxxxx xxxxxxx x xxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X,1-xxxxxxxx-3,3-xxx(2-xxxxxxx)-2-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
1-[2-(xxxxxxxxxxxx)xxxxx]-2-(4-xxxxxxxxxxxx)-5-xxxxx-1X-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-[2-(2-xxxxxxxxxxxxx)xxxxx]xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxx z xxxxxx pro xxxxxxx xxxxxxx |
Xxxxxxx x xxxxxx xxxxxxxx k přípravě xxxxxxxx xxxxxxxxx se xxxxxxxxxxxxxxxx xxxxxxx xxxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
X-(1-xxxxxx-2-xxxxxxxxxxxxxxx)xxxxxxxxxxxx |
|
|
Xxxxxxxxx |
(2XX,6X,11X)-3-xxxxxxxx-6,11-xxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxx-3-xxxxxxxxxx-8-xx |
|
|
Xxxxxxxxxx |
17-xxxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-[2-(xxxxxxxxxxx)xxxxx]xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α,14-xxxxx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxxxx |
xxxxx-4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxx-5-xxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
xxxxxx-1-xxxxxxxx-4-(X-xxxxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
2-(4-xxxxxxxxxxx)-1-[2-(xxxxxxxxxxxx)xxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
|
Xxxxxxx |
xxxxxxxx 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xxxxxx)xxxxx]xxx}xxxxxx |
|
|
Xxxx - list |
Kokový xxxx |
|
|
Xxxxxx |
(1X,2X,3X,5X)-3-(xxxxxxxxxx)-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxx |
|
|
Xxxxxxxxxx x xxxxxxxx |
Xxxxxxxxxxx x výrobě xxxxxxxxx xxxxxxx technologickou úpravou xxxxxxxx |
|
|
Xxxxxx xxxxxxx x xxxxxxxx |
X výjimkou xxxxx xxxxxx xxxxxxx a xxxxxxxx, která xxxxxxxx 1 % xxxxx xx skupiny tetrahydrokanabinolů x xxxxxxx podmínku xxxxxxxxxxx xxxxx xxxxxx x xxxxxx xxxxxxxxxxx xxxxxxx |
|
|
Xxxxxx xxx xxxxxxx xxxxxxx |
||
|
Xxxxxxxxxxxxxxxxx |
1-xxxxx-2-[9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-3-xxxxxxx-17-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxx xxxxxxxxxxxxxxx [(+)-3-xxxxxxx-17-xxxxxxxxxxxxxx] xx xxxxx xx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx v xxxx xxxxxxx |
|
Xxxxxxxxxxx |
(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
Xxxxxxxxxx |
(9X,13X,14X)-17-xxxxxxxxxxxxxx-3-xx |
Xxxxxxxxxxxxxx xxxxxxxxxxxx [(+)-3-xxxxxxx-17-xxxxxxxxxxxxxx] xx xxxxx ze xxxxxxx omamných xxxxx xxxxxxxxx x této xxxxxxx |
|
Xxxxxxxxx |
(2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3-xxxxxxxxx-8-xx |
|
|
Xxxxxxxx |
(6XX)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxx, meziprodukt |
4-(dimethylamino)-2,2-difenylpentannitril |
|
|
Methyldesorfin |
4,5α-epoxy-6,17-dimethylmorfin-6-en-3-ol |
|
|
Methyldihydromorfín |
4,5-epoxy-6,17-dimethylmorfínan-3,6-diol |
|
|
Metopon |
4,5-epoxy-3-hydroxy-5,17-dimethylmorfinan-6-on |
|
|
Moramid, xxxxxxxxxxx |
2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx |
3-Xxxxx fentanyl |
|
Methylthiofentanyl |
N-{(3RS)-3-methyl-1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
3-methylthiofentanyl |
|
Meziprodukt xxxxxx xxx léčebné použití |
základně xxxxxxxxxx xxxxxxxx konopí xxx xxxxxxx xxxxxxx xxxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-(2-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx |
|
|
Xxxxxx methobromid |
4,5α-epoxy-3,6α-dihydroxy-17,17-dimethylmorfin-7-en-17-ium-bromid |
a xxxx xxxxxxxx morfinu xx xxxxxxxxxx xxxxxxx xxxxxx xxxxxxxx xxxxxx-X-xxxxx |
|
Xxxxxx-X-xxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-17-xxxx |
|
|
Xxxxxxxxxxxxxxx |
4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
XXXX |
|
Xxxxxxx |
3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6-xx-xxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-xxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
4,4-xxxxxxx-6-(xxxxxxxxxxx)xxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-xxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxx |
4,5α-xxxxxxxxxxx-7-xx-3,6α-xxxx |
|
|
Xxxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxx |
Xxxxx homeopaticky xxxxxxxxxx xxxxxxxxx, jejichž stupeň xxxxxx xx vyšší xxx X4 xxxx XX2 |
|
|
Xxxxxxxx |
4,5α-xxxxx-6-xxxxxxx-17-xxxxxxxxxxxxx-6,8(14)-xxxx-3-xx |
|
|
Xxxxxxxx |
(5X)-4,5-xxxxx-14-xxxxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxx |
(5X)-4,5-xxxxx-3,14-xxxxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-4'-xxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-1-xxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
XXXXX |
|
Xxxxxxxx |
xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx A |
4-fenyl-1-methylpiperidin-4-karbonitril |
|
|
Pethidin, xxxxxxxxxxx X |
xxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxxxxx 4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxxx |
|
|
Xxxxxxxxx |
xxxxx-1-(3-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
1'-(3,3-xxxxxxx-3-xxxxxxxxxx)-4'-xxxxxx-1,4'-xxxxxxxxxxx |
|
|
Xxxxxxxxxxx |
4-xxxxx-1,3-xxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxxxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
(9XX,13XX,14XX)-3-xxxxxxx-17-xxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxx |
(3XX)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
Xxxxxxxxxx |
(9XX,13XX,14XX)-17-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxx |
xxxxxx-3-[4-(X-xxxxxxxxxxxxxxx)-4-(xxxxxxxxxxxxxxx)]xxxxxxxxxx]xxxxxxxxx |
|
|
Xxxxxxxxxx |
X-{4-(xxxxxxxxxxxxx)-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
3-[(1X,2X)-3-(xxxxxxxxxxxxx)-1-xxxxx-2-xxxxxxxxxxxx]xxxxx |
|
|
Xxxxxxx |
4,5α-xxxxx-3,6-xxxxxxxxx-17-xxxxxxxxxxxxx-6,8-xxxx |
|
|
Xxxxxxxx |
(5X)-4,5-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-6-xx-6-xx-xxxxxx |
|
|
Xxxxxxxxxxxx |
X-{1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxx |
xxxxx-(1XX,2XX)-2-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-3-xx-1-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(XX)-4-xxxxx-4-(1,2,5-xxxxxxxxxxxxxxxxxx-4-xx)xxxxxxxxx |
Xxxxxx xxxxxxx xxxxxxxx xxxxx uvedených x tomto xxxxxxx, xxxx estery x xxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx a xxxx xxxxxxxx látek xxxxxxxxx x xxxxx xxxxxxx, xxxxxx xxxx xxxxxxx, xxxxxx x éterů xx xxxxx xxxxxxxxx, xxx xxxx xxxx xxxxx xxxxxxxxx.
Xxxxxxx x. 2 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 2 xxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v českém xxxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxx |
(1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx |
|
|
Xxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx |
Xxxxxx izomerů omamných xxxxx xxxxxxxxx x xxxxx xxxxxxx, xxxx xxxx xxxxxxxx xxxxx xxxxxxxxx v xxxxx xxxxxxx, včetně solí xxxxxxx látek xxxxxxxxx x xxxxx xxxxxxx xx xxxxx případech, xxx xxxx xxxx xxxxx existovat.
Xxxxxxx x. 3 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 3 xxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx |
Xxxxx xxxxxxxxxxx nechráněný xxxxx xxxx xxxxx obecný xxxxx |
Xxxxxxxx název podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxx |
XXX 73750; xxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X-(1-xxxxxx-xxxxxxxxx-4-xx)-xxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxx |
||
|
Xxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxx-2-xxxxxx |
|
|
XX-7921 |
3,4-xxxxxxx-X-{[1-(xxxxxxxxxxxxx)xxxxxxxxxx]xxxxxx}xxxxxxxx |
||
|
XX-237 |
xxxxxxxxxx; 1-X-xxxxxxx-4-xxxxxxxxxxxxxxxxxx; |
1-[4-(3-xxxxxxxxx-2-xx-1-xx)xxxxxxxxx-1-xxxxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXX-X; xxxxxxxxxxxx-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-2X-1,3-xxxxxxxxxxx-5-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X-(1-xxxxxx-xxxxxxxxx-4-xx)xxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
Xxxxxx-X; X4129 |
X-xxxx\-X-[1-(xxxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxx |
|
|
Xxxxxxxxxxxx1xxxxxxx 1 |
Xxxxxx FuF |
N-(1-benzylpiperidin-4-yl)-N-fenylfuran-2-karboxamid |
|
|
Bromadolin |
U4793e;U47931E |
4-brom-N-(2-(dimethylamino)cyklohexyl)benzamid |
|
| Brorfin | Brorphine | 3-{1-[1-(4-bromfenyl)ethyl]piperidin-4-yl}-1H-benzimidazol-2-on | |
|
Butonitazen |
2-[(4-butoxyfenyl)methyl]-N,N-diethyl-5-nitro-1H-benzimidazol-1-ethanamin |
||
|
4-Chlorisobutyrfentanyl |
4-Cl-iBF |
N-(4-chlorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid |
|
|
Cyklopentylfentanyl |
Cyclopentyl-F; CP-F |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopentankarboxamid |
|
|
Cyklopropylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopropankarboxamid |
||
|
Desomorfin |
4,5α-epoxy-17-methylmorfinan-3-ol |
||
|
Despropionyl-2-fluor xxxxxxxx |
X-(2-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxxxxx-4-xxxxx xxxxxxxx |
X-(4-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
|
Xxxxxx |
xxxxxxxxxxxxxx |
2-[2-[(4-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx-1-xx]-X,X-xxxxxxxxxxxxxxxx |
|
| Xxxxxxxxxxxx | 2-[(4-xxxxxxxxxxx) xxxxxx-5-xxxxx-1-(2-xxxxxxxxxx-1-xxxxxxx)-1X-xxxx-xxxxxxxx | ||
|
Xxxxxxx |
(5X,6X,7X, 14X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx |
||
|
Xxxxxxxx xxxxxxxxx xxxxxx |
Xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]-xxxxxxxxx |
|
|
3-Xxxxxxxxxxxxxxxxxxxxxx |
β'-xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-3-xxxxxxxxxxxxxxx |
xxxxxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
X,X-xxxxxxx-2-{2-[(4-xxxxxxxxxx)xxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx-1-xx}xxxxxxxxx |
||
|
4-Xxxxx-xxxxxxxxxxxxx |
4X-XX |
X-(4-xxxxxxxxxx)-X-[(1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx)]xxxxxxxxx |
|
|
4-Xxxxx-xxxxxxxxxxxxxxxxxxxxxxxxx |
xxxx-xxxxxxxxxxxxxxxxxxxxxx-xxxxxxxx |
X-(4-xxxxxxxxxx)-X-(1-xxxxxxxxxxxxxxx-4-xx)-xxxxxxxxxxxxxxxxxxxxx |
|
|
2-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(2-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
2-XX, x-XX |
|
3-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(3-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
3-XX, x-XX |
|
4-Xxxxxxxxxxxxxxxxxxxx |
xxxx-xxxxxxxxxxxxxxxxxxxx; 4X-xxxxxxx xxxxxxxx |
X-(4-xxxxxxxxxx)-X-(1-xxxxxxxxxxxxxxxxx-4-xx)xxxxx-2-xxxxxxxxxx |
|
|
4-Xxxxxxxxxxxxxxxxxxxxx |
4X-xXX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
|
3-Xxxxxxxxxxxxxxxxxxxxxxxxxx |
xxxxx-xxxxxxxxxxxxxxxxxx-xxxxxxxx |
X-(3-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
Xxxxxxxxxxxxxxx |
XX-X; 2-furanoylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-furan-2-karboxamid |
|
|
(iso)Butyryl-F-fentanyl N-benzyl xxxxxx |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-(4-xxxxxxxxxx)xxxxxxxxx |
||
|
Xxxxxx |
(5X,6X)-4,5-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6-xxxx-xxxxxxxx |
||
|
4-xxxxxxxxxxxxxxxxxxxx |
4-XX-XX; xxxx-xxxxxxxxxxxxxxxxxxxxxx |
X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-xxxxxxxxx |
|
|
Xxxxxxxxx-X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-(xxxxxx-2-xx)xxxxxxxx |
||
|
Xxxxxxxxxxxx |
X,X-xxxxxxx-2-[[4-(1-xxxxxxxxxxxx)xxxxx]xxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx-1-xxxxxxxxx |
||
|
Xxxxxxxxxxx |
1-[4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxx-4-xx]xxxxxx-1-xx |
||
|
Xxxxxx |
X výjimkou xxxxxx pro xxxxxxx xxxxxxx xxxxxxx x xxxxxxx x. 1 |
||
|
Krotonylfentanyl |
(2E)-N-fsayl-N-[1-(2-fenylethyl)pipendin-4-yl]-2-butenamid |
||
|
Methoxyacetylfentanyl |
Methoxy-AcF |
2-methoxy-N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid |
|
|
4-Methoxybutyr xxxxxxxx |
4-XxX-XX |
X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxxxxxxx |
x-xxxxxxxxxxxxxxxxxxxx |
X-(2-xxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-xxxxxxxxx-4-xx]-xxxxxxxx |
|
|
2-Xxxxxx-XX-237 |
2-xxxxxx-xxxxxxxxxx |
1-[2-xxxxxx-4-(3-xxxxxxxxx-2-xx-1-xx)xxxxxxxxx-1-xxxxxxxx-1-xx |
|
|
3,4-Xxxxxxxxxxxxx-X-47700 |
3,4-XXX-X-47700; |
X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxx[x][1,3]xxxxxx-5-xxxxxxxxxx |
|
|
α-Xxxxxxxxxxxxxx xxxxxxxxx xxxxxx |
XX; B-F |
2-methyl-N-fenyl-N-[1-(1-fenylpropan-2-yl)piperidin-4-yl]propanamid |
|
|
3-Methylkrotonylfentanyl |
β'-methylkrotonylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)-piperidin-4-yl]-3-methylbut-2-enamid |
|
|
Metodesnitazen |
N,N-diethyl-2-[2-[(4-methoxyfenyl)methyl]benzimidazol-1-yl]ethanamin |
||
|
Metonitazen |
N,N-diethyl-2-[2-[(4-methoxyfenyl)methyl]-5-nitrobenzimidazol-1-yl]ethanamin |
||
|
MT-45 |
1-cyklohexyl-4-(1,2-difenylethyl)piperazin |
||
|
N-methyl X-47931X |
X-xxxxxxxxxxxxxxxx |
4-xxxx-X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxxxxx |
|
|
XXxxxxxxxx |
X-3217 |
X-(2-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
xxxxxxxxxxxxx, XXX, 127X49 |
1-(4,4-xx(xxxxxxx-2-xx)xxx-3-xx-2-xx)xxxxxxxxx |
|
| Xxxxxxxxxxxx | X,X-xxxxxxx-5-xxxxx-2-[(4-xxxxxxxxxxxx)xxxxxx]-1-X-xxxxxxxxxxxx-1-xxxxxxxxx) | ||
|
Xxxxxxxxxx x xxxxxx |
|||
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXX-X |
X-(1-xxxxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxxxxxxx-2-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX-xxxxxxxx; XXXX-X |
Ν-xxxxx-Ν-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxx |
2-xxxxxxxxxxx xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxx-2-xxxxxxxxxx |
|
|
X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
|
X-48800 |
2-(2,4-xxxxxxxxxxxx)-X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxxxxx |
||
|
X-49900 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
|
X-50488 |
3,4-xxxxxxx-X-xxxxxx-X-[2-(1-xxxxxxxxxxxx)xxxxxxxxxx] xxxxxxxxxxxxxx |
||
|
X-51754 |
2-(3,4-xxxxxxxxxxxx)-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
XXX, XX |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx; fentanyl xxxxxxxxxx xxxxxx |
Xxxxxx solí xxxxxxxx látek uvedených x xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx tyto xxxx xxxxx xxxxxxxxx.
Xxxxxxx x. 4 x xxxxxxxx xxxxx x. 463/2013 Sb.
Seznam x. 4 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx název (XXX) |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxx xxxxxx xxxxx |
Xxxxxxxx název podle XXXXX |
Xxxxxxxx |
|
1-(Xxxxxxxxxxxxxxxx)-2-[(4-xxxxxxxxxxx)xxxxxx]-X,X-xxxxxxx-1X-xxxxxxxxxxxx-5-xxxxxxxxxx |
|||
|
(+)-Xxxxxxxx |
XXX, LSD-25 |
(+)-8β-(3,3-dimethylureido)-6-methyl-9,10-didehydroergolin |
|
|
1-(2-(Methylamino)propanoyl)naftalen |
AMAPN |
2-(methylamino)-1-(naftalen-1-yl)propan-1-on |
|
|
1-(3-Trifluormethylfenyl)piperazin |
TFMPP |
1-[3-(trifluormethyl)fenyl]piperazin |
|
|
1-Nafýron |
1-naphyrone |
1-naftalen-1-yl-2-pyrrolidin-1-yl-pentan-1-on |
|
|
1p-LSD, 1X-XXX |
xxxxxxxxxxx xxxxxxxx 1-xxxxxxxxx xxxxxxxxx; (6xX,9X)-X,X-xxxxxxx-7-xxxxxx-4-xxxxxxxxx- -6,6a,8,9-tetrahydroindol[4,3-fg]chinolin-9-karboxamid |
||
|
2,3-Dimethylmetkathinon |
2,3-DMMC |
1-(2,3-dimethylfenyl)-2-(methylamino)propan-1-on |
|
|
2,3-Methylendioxymethkathinon |
2,3-MDMC |
1-(1,3-benzodioxol-4-yl)-2-(methylamino)propan-1-on |
|
|
2,4,5-Trimethylmethkathinon |
2,4,5-TMMC |
||
|
2,4,6-Trimethoxyamfetamin |
TMA-6 |
1-(2,4,6-trimethoxyfenyl)propan-2-amin |
|
|
2,4-Dimethylethkathinon |
2,4-DMEC |
1-(2,4-dimethylfenyl)-2-(ethylamino)propan-1-on |
|
|
2,4-Dimethylmetkathinon |
2,4-DMMC |
1-(2,4-dimethylfenyl)-2-(methylamino)propan-1-on |
|
|
2',4'-Dimethyl-α-pyrrolidinpropiofenon |
2,4-DMPPP |
1-(2,4-dimethylfenyl)-2-pyrrolidin-1-yl-propan-1-on |
|
|
2,5-Dimethoxy-4-chloramfetamin |
DOC |
1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin |
|
|
2,5-Dimethoxy-4-jodamfetamin |
DOI |
1-(4-jod-2,5-dimethoxyfenyl)propan-2-amin |
|
|
25B-NBOMe |
2-(4-brom-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
Cimbi-36 |
|
|
25C-NBOMe |
2-(4-chlor-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
2C-C-NBOMe |
|
|
25I-NBF; 25X-XX2X; 2X-X-XXX, NBF-2C-I; Xxxxx-21 |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X[(2-xxxxxxxxxx)xxxxxx]xxxxxxxxx |
||
|
25X-XXXX |
2-{[2-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxxxxxx]xxxxxx}xxxxx |
2X-X-XXXX; Xxxxx-27 |
|
|
251-XXXXx |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
XXXXx-2X-X |
|
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
2X-X-XXX |
2X-X-XXX |
2-(4-xxxx-2,3,6,7-xxxxxxxxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxxxxx |
|
|
2X-X |
2X-X |
2,5-xxxxxxxxx-4-xxxxxxxxxxxxxxxxxx |
XX-25 |
|
2X-X |
2X-X |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-2-xxxxxxxxxxx-1-(2-xxxxxxxxxx)xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxxxxx |
2-Xx-2'-Xxx-XXX, |
2-(2-xxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX; 2-xxxxxxxxxxxxxxxxxxxx |
X-xxxxx-1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
2X-XXXXX; XXX-13 |
8-xxxxxxxxxx-3-[(4,4-xxxxxxφxxxxxxxx-1-xx)xxxxxxxx]-4-xxxxxxxxxxxxx |
||
|
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
2-XXXX |
1-(xxxxxxxxxx-2-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
2-Xxxxxxxxxxxxxxx |
X-xxxxxx-xx-XXXX-2 |
1-(6-xxxxxxx-1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxxx |
2-XX |
(2XX)-1-(2-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
2-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
2-XXXX |
1-(2-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
2-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
2-XXXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)-xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxxxxxxx |
2-XXX |
(2XX)-1-[2-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxx-3-xxxxxxx-xxxxxxxxxxx |
α-XXX-XxX; XXxXXX |
3-xxxxxxx-1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
3-(4-Xxxxxxxxxxxxxxxxxxxx)-1-xxxxxxxxxxx |
Xxx High |
[4-(hydroxymethyl)fenyl]-(1-pentyl-1H-indol-3-yl)methanon |
|
|
3-(p-Methoxybenzoyl)-N-methylindol |
(4-methoxyfenyl)(l -methyl-1H-indol-3-yl)methanon |
||
|
3',4'- Xxxxxxxxxxxxx-α-xxxxxx XXX |
XXXXX |
1-(3,4-xxxxxxxxxxxxxxxxxx)-2-xxxxxx-2-xxxxxxxxxxxxxxxxxx-1-xx |
|
|
3,4-Xxxxxxxxxxxxxxxxxx |
3,4-XXXX; |
1-(3,4-xxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
3,4-Xxxxxxxxxxxxxxxxxxxx |
3,4-XXXX |
xxxxxx (2R)-2-(3,4-dichlorfenyl)-2-[(2R)-pipendin-2-yl]acetát |
|
|
3,4-Dichlor-N,N-cyklohexylmethylmeth-kathinon |
3,4-DCCHMMC |
2-(cyklohexylmethylamino)-1-(3,4-dichlorfenyl)propan-1-on |
|
|
3,4-Dimethoxy-α-PHP |
3,4-DMeO-α-PHP |
1-(3,4-dimethoxyfenyl)-2-(pyrrolidin-1-yl)hexan-1-on |
|
|
3,4-Dimethylethkathinon |
3,4-DMEC |
1-(3,4-dimethylfenyl)-2-(ethylamino)propan-1-on |
|
|
3,4-Dimethylmetkathinon |
3,4-DMMC |
1-(3,4-dimethylfenyl)-2-(methylamino)propan-1-on |
|
|
3,4-Dimethyoxy-α-pyrrolidinovalerofenon |
3,4-DMeO-α-PVP |
1-(3,4-dimethoxyfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
|
|
3,4-Methylendioxypyrovaleron |
MDPV |
1-[3,4-(methylendioxy)fenyl]-2-(pyrrolidin-1-yl)pentan-1-on |
MDPK |
|
3',4'-Methylendioxy-α-pyrrolidinbutyro-fenon |
MDPBP |
(RS)-1-(3,4-methylendioxyfenyl)-2-(1-pyrrolidinyl)butan-1-on |
|
|
3 ',4'-Xxxxxxxxxxxxx-α-XXX |
XXXXX |
1-(3,4-xxxxxxxxxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx |
|
|
3 -Xxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-2-xxxxxxxxxxx-1-(3-xxxxxxxxxx)xxxxxx-1-xx |
|
|
3X-Xxxxxxxxxxx |
3-XXX; XXX-593 |
2-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX; 3-xxxxxxxxxxxxxxxxxxxx |
X-xxxxx-1-(3-xxxxxxxxxx)xxxxxx-2-xxxx; N-ethyl-3-fluoramfetamin |
|
|
3-Fluorethkathinon |
3-FEC |
1-(3-fluorfenyl)-2-(ethylamino)propan-1-on |
|
|
3-Fluormethamfetamin |
3-FMA |
(RS)-1-(3-fluorfenyl)-N-methylpropan-2-amin |
|
|
3-Fluormethkathinon |
3-FMC |
1-(3-fluorfenyl)-2-(methylamino)propan-1-on |
|
|
3-Fluor-α-PVP |
3F-α-PVP; 3X-XXX |
1-(3-xxxxxxxxxx)-2-(1-xxxxxxxxxx)xxxxxx-1-xx |
3-Xxxxx-α-XXX |
|
3-Xxxxxxxxxxxxxxxx |
3-XXX, XXXX, 3-oxyfenazepam, 3 -xx xxxxx xxxxxxxxx |
7-xxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XX-XXX; |
3-[1-(xxxxxxxxx-1-xx)xxxxxxxxxx] xxxxx |
|
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-XXXX |
1-(xxxxxxxxxx-3-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
3-Xxxxxxx xxxxxxxxxxx |
3-XxX-XXX |
X-xxxxx-1-(3-xxxxxxxxxxxx)xxxxxxxxxx-1-xxxx |
|
|
3-Xxxxxxx fencyklidin |
3-MeO-PCP |
1-[1-(3-methoxyfenyl)cyklohexyl]piperidin |
|
|
3-Methoxymethkathinon |
3-MeOMC |
1-(3-methoxyfenyl)-2-(methylamino)propan-1-on |
|
|
3-Methyl-4-fluormethkathinon |
3-Methylflefedron |
1-(4-fluor-3-methylfenyl)-2-(methylamino)propan-1-on |
|
|
3-Methylamfetamin |
3-MA |
(2RS)-1-(3-methylfenyl)propan-2-amin |
|
|
3-Methylethkathinon |
3-MEC |
2-(ethylamino)-1-(3-methylfenyl)propan-1-on |
|
|
3-Methylmetamfetamin |
3-MMA |
1-(3-methylfenyl)-N-methylpropan-2-amin |
|
|
3-Methylmetkathinon |
3-MMC |
2-(methylamino)-1-(3-methylfenyl)propan-1-on |
|
|
3-Methyl-N,N-dimethylkathinon |
3-MDMC |
1-(3-methylfenyl)-2-(dimethylamino)propan-1-on |
|
|
3-Methyl-N-ethylnorpentedron |
3-MEAP |
2-(ethylamino)-1-(3-methylfenyl)-pentan-1-on |
|
|
3-Methylthioamfetamin |
3-MTA |
(2RS)-1-[3-(methylsulfanyl)fenyl]propan-2-amin |
|
|
4'-Fluor-4-methylaminorex |
4-FPO; x-X-4-xxxxxxxxxxxxxx |
5-(4-xxxxxxxxxx)-4,5-xxxxxxx-4-xxxxxx-2-xxxxxxxxxx |
|
|
4'-Xxxxxx-X-xxxxxxxxxxxxxxxxxx |
4'-xxxxxx-XxXX |
1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
XXXX |
(XX)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxxxxx |
4'-xxxxxx-α-XxXX |
4-xxxxxx-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4'-xxxxxx-α-XXX; MPPP |
(RS)-1-(4-methylfenyl)-2-(1-pyrrolidinyl)propan-1-on |
|
|
4'-Ethyl-α-PVP |
4'-ethyl-α-pyrrolidinopentiofenon |
1-(4-ethylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
|
|
4-Acetoxy-N-methyl-N-ethyltryptamin |
4-AcO-MET |
{3-[2-(ethylmethylamino)ethyl]-1H-indol-4-yl}acetát |
|
|
4-Bromethkathinon |
4-BEC |
1-(4-bromfenyl)-2-(ethylamino)propan-1-on |
|
|
4-Brommethkathinon |
4-BMC |
(RS)-1-(4-bromfenyl)-2-(methylamino)propan-1-on |
Brefedron |
|
4-Brom-α-pyrrolidinvalerofenon |
4Br-α-PVP |
1-(4-bromfenyl)-2-pyrrolidin-1-yl-pentan-1-on |
|
|
4-Brom-α-pyrrolidinpropiofenon |
4Br-α-PPP; pBPPP, 4Xx-XXX |
1-(4-xxxxxxxxx)-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-2-xxxxxxxxxxx-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
|
4X-Xxxxxxxxxxx |
4-XXX |
2-(4-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxx-1-xx |
||
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4X-XXX; p-fluoroethylphenidate |
ethyl-2-(4-fluorfenyl)-2-(2-piperidyl)acetát |
|
|
4-Fluorkathinon |
4-FC |
2-amino-1-(4-fluorfenyl)-propan-1-on |
|
|
4-Fluormethamfetamin |
4-FMA |
(RS)-1-(4-fluorfenyl)-N-methylpropan-2-amin |
|
|
4-Fluormethkathinon |
4-FMC |
1-(4-fluorfenyl)-2-(methylamino)propan-1-on |
Flefedron |
|
4F-MPH; 4-XXXX |
Xxxxxx-2-(4-xxxxxxxxxx)-2-(2-xxxxxxxx)xxxxxx |
4X-XXX |
|
|
4-Xxxxx-X-xxxxxxxxxxxxx |
4X-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxx-1-xx |
|
|
4-Xxxxx-X-xxxxxxxxxxxxxx |
4X-XXX; 4-xxxxx-α-xxxxxxxxxx-xxxxxxxxxxx |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxx-X-xxxxxxxxxxxxxxxxxxxxx |
4X-XXX; 4X-XXX; 4X-XXXX |
1-(4-xxxxxxxxxx)-2-(1-xxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxx |
4-XXX; 4-X-xxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-xxxxxx-α-XXX; 4X-XXX; X-2370 |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxx |
4X-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4X-α-XXX; 4X-XX8 |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-X-α-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxxxx |
4X-xxxxx-XXxX; 4X-α-XxXX |
1-(4-xxxxxxxxxx)-4-xxxxxx-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4X-α-XXX; 4X-XX9 |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
4X-XXXX-XXXX |
xxxxxx (X)-2-({[1-(4-xxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
|
4X-XXXX-XXXXXX; 4X-XXX |
xxxxxx (S)-2-({[1-(4-fluorbutyl)-1H-indazol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát |
||
|
4-F-α-PVP xxxxxxxxx xxxxxx |
1-(4-xxxxxxxxxx)-2-(1-xxxxxxxxx)xxxxxx-1-xx |
||
|
4-XXXXXXX |
4-xxxxxxx-3,3,4-xxxxxxxxx-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxxx-1-xx |
||
|
4-Xxxxxxx-X-xxxxxx-X-xxxxx tryptamin |
4-HO-MET |
3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-ol |
Metocin; Xxxxxxxxxxx |
|
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxx xxxxxxxxx |
4-XX-XxXX |
3-{2-[xxxxxx(xxxxxx-2-xx)xxxxx]xxxxx}-1X-xxxxx-4-xx |
Xxxxxxxx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4-Xx-α-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
XXX |
|
4-Xxxxxxxxxxxxx |
Xx5-4864, chlorodiazepam |
7-chlor-5-(4-chlorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
|
|
4-Chlorethkathinon |
4-CEC |
1-(4-chlorfenyl)-2-(ethylamino)propan-1-on |
|
|
4-Chlorisopropylkathinon |
4-CIC; xxxxxxxxxxx, |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
x-XXX \ |
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
4-Xxxxx-X,X-xxxxxxxxxxxxxxxx |
4-XXX; 4-CDMD |
1-(4-chlorfenyl)-2-(N,N-dimethylamino)propan-1-on |
|
|
4-Chlor-N-butylkathinon |
4-CBC |
2-(butylamino)-1-(4-chlorfenyl)propan-1-on |
4-Chlorbutylkathinon |
|
4-Chlorpentedron |
4-CPD |
1-(4-chlorfenyl)-2-(methylamino)pentan-1-on |
|
|
4-Chlor-α-pyrrolidinpropiofenon |
4-chlor-α-PPP |
1-(4-chlorfenyl)-2-(1-pyrrolidinyl)propan-1-on |
|
|
4-MAPB |
4-MAPB |
1-(benzofuran-4-yl)-N-methylpropan-2-amin |
|
|
4-Methoxy-α-pyrrolidinbutiofenon |
4-MeO-α-PBP; 4-XXXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4-XxX-α-XXX; 4-XxX-α-XX8 |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-xxxxxxx α-XXX; 4-XxX-α-XX9 |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-XxX-α-XXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
4'-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4'-Xxxxxxx-α-XXX; MOPPP |
(RS)-1-(4-methoxyfenyl)-2-(1-pyrrolidinyl)propan-1-on |
|
|
4-MA |
|||
|
4-Methylbufedron |
4-Me-MABP |
2-(methylamino)-1-(4-methylfenyl)butan-1-on |
|
|
4-Methylethkathinon |
4-MEC |
2-(ethylamino)-1-(4-methylfenyl)propan-1-on |
|
|
4-Methylkathinon |
Normefedron; 4-XX |
2-xxxxx-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxx |
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxx-X,X-xxxxxxxxxxxxxxx |
2-xxxxxxxxxxxx-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
||
|
4-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
4-XXXX |
1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-xxxxxx-X-xxxxxxxxxxxxxx |
(4-XXX) |
(±)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
4-XXXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)-xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
XXXX |
(XX)-1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxx-1-xx |
|
|
4-XXX |
1-(4-xxxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxx-1-xx |
||
|
5 - Xxxxxxxxxxxxxxxx |
5-XXX |
5-(2-xxxxxxxxxxx)xxxxx |
|
|
5-XXXx; xxxxxxx-α-XXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
|
5X-XXX48; 5X-XXXXXXX |
X-(1-xxxxxxxxx)-1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
|
5Xx-XX-XXXXXX |
X-[(2X)-1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx]-1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
|
5Xx-XXXX-XXXXXX; 5Xx-XXX |
xxxxxx 2-{[1-(5-chlorpentyl)-1H-indazol-3-karbonyl]amino}-3,3-dimethylbutanoát |
||
|
5-Cl-pentyl XXX 018 xxxxxxx xxxxxx |
5Xx-XXX-018; 5Xx-XXX-018-X, XXX-018 xxxxxx xxxxxxxx |
[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
|
|
5 -Dihydrobenzofuranpyrovaleron |
5-DBFPV; XXXX |
1-(2,3-xxxxxxxxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
5-XXXX |
1-(1-xxxxxxxxxx-5-xx)-X-xxxxxxxxxxx-2-xxxx |
||
|
5X-3,5-XX-XXXXXXXX; 5X-3,5-XX-XXXXXXX, XX-037 |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-3-(4-xxxxxxxxxx)-1X-xxxxxxx-5-xxxxxxxxxx |
||
|
5X-5,3-XX-XXXXXXXX; 5X-XX-XXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-5-(4-xxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XX-X7XXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XX-XXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
5X-XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XXX48 |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XXX57 |
xxxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
5X-XXX-XXXX |
xxxxxx (2X)-2-[[1-(5-xxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxxxxxxxxxx |
||
|
5X-XXX-XXXXXX; 5F-AMB |
methyl-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3-methylbutanoát |
5F-AMP |
|
|
5F-A-P7AICA |
N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-pyrrolo[2,3-b]pyridin-3-karboxamid |
||
|
5F-APP-PICA |
N-(1-amino-1-oxo-3-fenylpropan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid |
||
|
5F-APP-PINACA |
N-(2-amino-1-benzyl-2-oxo-ethyl)-1-(5-fluorpentyl)indazol-3-karboxamid |
||
|
5F-CUMYL-PEGACLONE |
5-(5-fluorpentyl)-2-(1-methyl-1-fenylethyl)-pyrido[4,3-b]indol-1-on |
||
|
5F-EDMB-PINACA |
ethyl 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx |
||
|
5X-XXX-XXXXXX |
xxxxx 2-[[1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxx-xxxxxxxx |
||
|
5X-XXX-398; XX-2201; |
(4-chlornaftalen-1-yl)[1-(5-fluorpentyl)-1H-indol-3-yl]-methanon |
||
|
5F-MDMB-P7AICA |
methyl-2-{[1-(5-fluorpentyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]formamido}-3,3-dimethyl xxxxxxxx |
||
|
5X-XXXX-XXXX; |
xxxxxx (S)-2-({[1-(5-fluorpentyl)-1H-indol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát |
||
|
5F-MDMB-PINACA; 5X-XXX |
xxxxxx (X)-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
|
5X-XXXX-2 |
1-(5-xxxxxxxxxxx)-X-(xxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
5X-XX-22 indazol xxxxxx |
xxxxxxxx-8-xx 1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XX-22; 5F-QUPIC |
8-chinolinyl ester xxxxxxxx 1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxxx |
||
|
5-X-xxxxxx-3-xxxxxxxxxxxxxxx |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (xxxxxxx-3-xx)xxxxxxxx |
||
|
5X-XX-XXXX |
1-(5-xxxxxxxxxxx)-3-(xxxxxxxxxx-1-xxxxxxxx)-1-X-xxxxx |
||
|
5X-XX-XXXXXX |
[1-(5-xxxxxxxxxxx)xxxxxxx-3-xx]-xxxxxxxxxx-1-xx-xxxxxxxx |
||
|
5X-XXX-005 |
xxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XXX-006 |
X-xxxxxx-1-(5-xxxxxxxxxxx)-x X-xxxxx-3-xxxxxxxxxx |
||
|
5XXX-144 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXX-11 |
|
|
5-XXXX |
1-(xxxxxxxxxx-5-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
5-XxX-XXX |
5 -xxxxxxx-α-xxxxxxxxxxxxxxx |
||
|
5-XxX-XXXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-(xxxx-2-xx-1-xx)xxxx-2-xx-1-xxxx |
||
|
5-XxX-XxXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-xxxxxxxxxxxx-2-xxxx; 5-xxxxxxx-X-xxxxxx-X-xxx-xxxxxx xxxxxxxxx |
||
|
5-Xxxxxxxxxxxx Ion |
N-methyl-bk-MMDA-5 |
1-(7-methoxybenzo[d] [1,3]xxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
5-XXXx |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
|
6-XXX |
6-(2-xxxxxxxxxxx)xxxxxxxxxx |
||
|
6-XXXX |
1-(1-xxxxxxxxxx-6-xx)-X-xxxxxxxxxxx-2-xxxx |
||
|
6-XXXX |
1-(xxxxxxxxxx-6-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
7-XXXX |
1-(xxxxxxxxxx-7-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
X-796,260 |
[1-(2-xxxxxxxx-4-xxxxxxx)-1X-xxxxx-3-xx]-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
X-796,260 izomer |
((E)-1-(1-(2-morfolm-1-yl)ethyl)indol-3-yl)-3,4,4-tnmethylpent-2-en-1-on |
||
|
A-834,735 |
1-(tetrahydropyran-4-ylmethyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyklopropyl)methanon |
||
|
A-836,339 |
N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-yliden]-2,2,3,3-tetramethylcyklopropan-karboxamid |
||
|
AB-005 |
[1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyklopropyl)-methanon |
||
|
AB-005 xxxxxx xxxxxx |
(1-(1-xxxxxxxxxxxx-2-xx)-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
XX-XXXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XX-XXXXXXXX |
N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1-[(2-fluorfenyl)methyl]-1H-indazol-3-karboxamid |
||
|
AB-CHMFUPPYCA; |
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyklohexylmethyl)-3-(4-fluorfenyl)-1H-pyrazol-5-karboxamid |
||
|
AB-CHMINACA |
N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-l(cyklohexylmethyl)-1H-indazol-3-karboxamid |
||
|
AB-PINACA |
N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1-pentyl-1H-indazol-3-karboxamid |
||
|
AB-PINACA |
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluorpentyl)-1H-indazol-3-karboxamid |
||
|
Adamantyl-THPINACA |
N-(1-adamantyl)-1-(tetrahy xxxxxxxx-4-xxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXXXX |
X-[1-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxx]-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxx-xxxx |
||
|
XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-\X- indazol-3-karboxamid |
||
|
Adinazolam |
U 41123 |
1-(8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxx[4,5-x][1,4]xxxxxxxxxxxxx-1-xx)-X,X-xxxxxxxxxxxxxx xxxx |
|
|
X-XXXXXXXX |
X-(1-xxxxxxxxx)-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-57 |
Xxxxxxx-1-xx-1-xxxxxxxxxxxxx-3-xxxxxxxxxx |
||
|
XX-XXX |
(6xX,9X)-7-xxxxx-X,X-xxxxxxx-6,6x,8,9-xxxxxxxxxx-4X-xxxxx[4,3-xx]xxxxxxx-9-xxxxxxxxxx |
6-xxxxx-6-xxx-XXX |
|
|
Xxxxxxxxxx triazolbenzofenon xxxxxxx |
(2-(3-(xxxxxxxxxxx)-5-xxxxxx-4-X-1,2,4-xxxxxxx-4-xx)-5-xxxxxxxxxx)(xxxxx)xxxxxxxx |
||
|
XX-1220 |
1-[(1-xxxxxxxxxxxxxxx-2-xx)xxxxxx]-1X-xxxxx-3-xx}(xxxxxx)-xxxxxxxx |
||
|
XX-1220 xxxxxx xxxxxx |
1-(1-xxxxxxxxxxxx-3-xx)-1X-xxxxx-3-xx] (naftyl)methanon |
||
|
AM-1248 |
adamant-1-yl(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)methanon |
||
|
AM-1248 xxxxxx xxxxxx |
xxxxxxx-1-xx(1-(1-xxxxxxxxxxxx-3-xx)-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (naftalen-1-yl)methanon |
||
|
AM-2201 xxxxxxxxxxxx xxxxxx; XXXXXXXX |
(1-(5-xxxxxxxxxxx)-1X-xxxxx[x]xxxxxxxx-2-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
|
XX-2201 xxxxxxx karboxamid xxxxxx |
X-1-xxxxxxxxxx-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XX-2232 |
5-[3-(1-xxxxxxx)-1X-xxxxx-1-xx]xxxxxxxxxxxx |
||
|
XX-2233 |
1-[(X-xxxxxxxxxxxxxxx-2-xx)xxxxxx]-3-(2-xxxxxxxxxx)xxxxx |
||
|
XX-6527 |
1-xxxxxx-X-(xxxxxxxx-1-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
XX-6527 5-xxxxxxxxxxx xxxxxxx |
1-(5-xxxxxxxxxxx)-X-(xxxxxxxx-1-xx)-1X-xxxxx-3-xxxxxxxxx |
||
|
XX-679 |
(2-xxxxxxxx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XX-694 |
1-[(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(2-xxxxxxxx)xxxxxxxx |
||
|
XX-694 (xxxxx xxxxxxxxx xxx) |
1-(5-xxxxxxxxxxx)-3-(2-xxxxxxxxxxxx)xxxxx |
||
|
XX-694 (methyl xxxxxxxxx iod) |
1-(5-fluorpentyl)-3-(2-methylbenzoyl)indol |
||
|
AM-694 xxxxx xxxxxxx |
1-[(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(2-xxxxxxxx)xxxxxxxx |
||
|
XXX-4xx-XXXX |
xxxxxx-3-xxxxxx-2-[1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xxxxxxxxxxx]xxxxxxxx |
||
|
XXX-XXXXXX |
xxxxxx 2-[[1-[(4-fluorfenyl)methyl]indol-3-karboxamid]-3-methylbutanoát |
||
|
AMB-FUBINACA; XXX-XXX |
Xxxxxx 2-({1-[(4-xxxxxxxxxx)xxxxxx]-1X-xxxxxxx-3-xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
XXX-XXXXXXXX |
|
|
XXX-XXXXXX |
Xxxxxx (2X)-2-{[1-(xxxxxxxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx}-3-xxxxxxxxxxxxxx |
||
|
XXX-XXXxXXXX |
xxxxxx 2-(1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx)-3-xxxxxxxxxxxxxx |
||
|
XXXXX; XXX-001, 2XX1 |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXXXXXX |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
XXX48 |
|
|
XXX-XXXXXX |
X-(1-xxxxx-1-xxx-3-xxxxxxxxxxx-2-xx)-1-xxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXXXX |
X-(2-xxxxx-1-xxxxxx-2-xxx-xxxxx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXXXX |
X-(2-xxxxx-1-xxxxxx-2-xxx-xxxxx)-1-(xxxxxxxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
|
xx-2X-X; βx-2X-X |
2-xxxxx-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xx |
||
|
xx-XXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
||
|
xx-XXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxx-1-xx |
||
|
xx-XXX |
2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx-1-xx |
||
|
XXXX |
2-xxxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxx-1-xx |
||
|
XXXX; 3,4-XXXX |
2-xxxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxx |
8-xxxx-6-xxxxx-1-xxxxxx-4X-xxxxx[x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
||
|
Xxxxx-Xxxxxxxxx |
(2X)-1-(4-xxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxx-2-xxxx |
||
|
Xxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxx-1-xx |
|
|
XXX-018 |
xxxxxxxx-1-xx 1-pentyl-1H-indol-3-karboxylát |
||
|
CP 47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxxx-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
|
XX 47,497 (C8 + X2) |
2-((1X,3X)-3-xxxxxxxxxxxxxxxxx)-5-(2-xxxxxxxxxxx-2-xx)xxxxx; 2-((1X,3X)-3-xxxxxxxxxxxxxxxxx)-5-(xxxxx-3-xx)-xxxxx |
1,1-xxxxxxxx x 1-xxxxx derivát X8-xxxxxxxx |
|
|
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
XX-13 |
|
|
XXXXX-4XX-X7XXXX |
1-(4-xxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
|
XXXXX-4XX-XXXXXX; XXX-78 |
1-(4-xxxxxxxxxx)-X-(1-xxxxxx-1-xxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
|
XXXXX-5X-X7XXXX |
1-(5-x:xxxφxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
|
XXXXX-5XXXXX |
1-(5-xxxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXXXX-5XXXXXXX |
|||
|
XXXXX-XXXX |
1-xxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXXXX-XX-XXXXXXXXX |
5-(xxxxxxxxxxxxxxxx)-2-(1-xxxxxx-1-xxxxx-xxxxx)xxxxxx[4,3-x]xxxxx-1-xx |
||
|
XXXXX-XXXXXXXXX; SGT-151 |
2-(1-methyl-1-fenylethyl)-5-pentyl-pyrido[4,3-b]indol-1-on |
||
|
CUMYL-PICA |
1-pentyl-N-(2-fenylpropan-2-yl)-1H-indol-3-karboxamid |
||
|
CUMYL-PINACA |
1-pentyl-N-(2-fenylpropan-2-yl)-1H-indazol-3-karboxamid |
||
|
CUMYL-THPINACA |
N-(2-fenylpropan-2-yl)-1-((tetrahydro-2H-pyran-4-yl)methyl)-1-H-indazol-3-karboxamid |
||
|
DBZP |
1,4-dibenzylpiperazin |
||
|
Deschloretizolam |
ETZ-2; xxxxxxxx-2 |
2-xxxxx-9-xxxxxx-4-xxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|
|
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-2-xxxxxxxxxxxxxxx-1-xx |
||
|
Xxxxxxxx-X-xxxxx-xxxxxxx |
X-XXX; 2-Xxx-XXX, xxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-xxxxxxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)-1-xxxxxxx |
Xxxxxxxxxxxxx |
|
Xxxxxxxxxx |
2-xxxxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
Xx 5-3448 |
|
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx] xxxx |
|
|
Xxxxxxxxx |
XXX; 1,2-XXX; XXXX |
1-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
XX1X4X21 |
|
Xxxxxxxxxxxxx |
Xx 07-4065 |
7-xxxxx-5-(2,6-xxxxxxxxxxxx)-1-xxxxxx-3X-1,4-xxxxxxxxxxxxx-2-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XX-4662 |
1-(3,4-xxxxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[4-(xxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
|
|
Xxxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
3,4-xxxxxxxxxxxxxxx- methylkathinon |
|
Dimethyltriptamin |
DMT |
N-[2-(indol-3-yl)ethyl]-N,N-dimethylamin |
|
|
Dipentylon |
2-(dimethylamino)-3΄,4΄-(methylendioxy)valerophenone |
1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-pentan-1-on |
|
|
DMBA-CHMINACA |
2-(1-(cyklohexylmethyl)-1H-indazol-3-karboxamido)-3,3-dimethylbutanová xxxxxxxx |
||
|
XXX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(4-xxxxx-xxxxxxxx-1-xx)xxxxxxxx |
||
|
Xxxxxxxx |
XXXXX; ephenidine; XXX |
X-xxxxx-1,2-xxxxxxxxxxxxxxxx |
|
|
XX-018 |
xxxxxxxx-1-xx(9-xxxxxx-9X-xxxxxxxx-3-xx)xxxxxxxx |
||
|
XX-2201 |
(9-(5-xxxxxxxxxxx)-9X-xxxxxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-XXXXXXXX |
Xxxxx 2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxx-xxxxxxxx |
||
|
Xxxxxxx |
XXXXX; bk-EBDP |
1-(benzo[d] [1,3]xxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
X-xxxxx-xxxxxxxx |
|
Xxxxxxxxxxx |
Xxxxxxxxxxxx; X-xxxxxxxxxxxxxx; ETH-CAT |
2-ethylamino-1-fenyl-propan-1-on |
|
|
ETH-LAD |
(6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindo1-[4,3-fg]chinolin-9-karboxamid |
||
|
Ethylfenidát |
(RS)-ethyl-2-fenyl-2-piperidin-2-ylacetát |
||
|
Ethylon |
bk-MDEA |
2-ethylamino-1-(3,4-methylendioxyfenyl)propan-1-on |
|
|
Ethyltenamfetamin |
MDE, XXXX |
(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxx |
XXX |
X-xxxxx-1-xxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxx |
XXX3219; Xxxxx |
4-(2-xxxxxxxxxx)-2-xxxxx-9-xxxxxx-67/-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)xxxxx |
||
|
Xxxxxxx |
xx-XXXX, N-Ethylbutylone |
1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-on |
|
|
FDU-PB-22 |
1-naftyl 1-[(4-xxxxxxxxxx)xxxxxx]xxxxx-3-xxxxxxxxxx |
||
|
Xxxxxxx |
xxxxxxxx |
4-xxxxx-3-xxxxxxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxxxxx |
Xx 11-5073/000 |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx -4X- [1,2,4]xxxxxxx[4,3-x] [1,4]benzodiazepin |
|
|
Flubromazepam |
7-brom-5-(2-fluorfenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Flubromazolam |
8-brom-6-(2-fluorfenyl)-1-methyl-4H-[1,2,4]tnazolo-[4,3a] [1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
2-xxxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-x] [1,2,4]xxxxxxx[4,3-x] [1,4] diazepin |
||
|
Flunitrazolam |
6-(2-fluorfenyl)-1-methyl-8-mtro-4H-[1,2,4]tnazolo[4,3-a] [1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
Xx 05-4435 |
5-(2-fluorfenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-on |
|
|
FUB-144 |
[1-[(4-fluorfenyl)methyl]indol-3-yl]-(2,2,3,3-tetramethylcyklopropyl)methanon |
||
|
FUB-AKB48 |
N-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboxamid |
||
|
FUB-JWH-018 |
(1-(4-fluorbenzyl)-1H-indol-3-yl)(naftalen-1-yl)methanon |
||
|
FUB-NPB-22 |
chinolin-8-y1-(4-fluorbenzyl)-1H-indazol-3-karboxylát |
||
|
FUB-PB-22 |
chinolin-8-yl-1-(4-fluorbenzyl)-1H-indol-3-karboxylát |
||
|
Hexedron |
β-propylmethcathinone |
2-(methylamino)-1-fenylhexan-1-on |
|
|
Hexylon |
βk-MBDH |
1-(1,3-benzodioxol-5-yl)-2-(methylamino)hexan-1-on |
|
|
HU-210 |
(6aR, 10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloktan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol |
||
|
HU-331 |
3S,4R-p-benzochinon-3-hydroxy-2-p-mentha-(1,8)-dien-3-yl-5-pentyl |
||
|
Hydroxytenamfetamin |
(2R,S)-N-hydroxy-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
||
|
Indapyrofenidon |
1-(2,3-dihydro-1H-inden-5-yl)-2-fenyl-2-(pyrrolidin-1-yl)-ethanon |
||
|
Ioddimethoxyfenethylamin |
2C-I |
(4-iod-2,5-dimethoxyfenylethyl)amin |
|
|
Isohexedron |
4-methyl-2-(methylamino)-1-fenylpentan-1-on |
||
|
Isopropylfenidát |
IPPD |
isopropyl2-fenyl-2-(2-piperidyl)acetát |
|
|
JTE-907 |
N-(Benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydrochinolin-3-karboxamid |
||
|
JWH 018 X-5-xxxxxxxxxx xxxxxxx |
[1-(5-xxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX 018 X-5-xxxxxxxxxxx xxxxxxx |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-007 |
1-xxxxxx-2-xxxxxx-3-(1-xxxxxxx)xxxxx |
||
|
XXX-018 |
(xxxxxxxx-1-xx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-018 xxxxxxxxxx xxxxxxx; |
1-xxxxxx-3-(xxxxxxx-1-xxx)xxxxx |
||
|
XXX-018 xxxxxxxxxxxxxxx xxxxxxx |
[1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xx] (xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-018 |
xxxxxxxx-8-xx-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXX-018 xxxxxxx xxxxxx |
1-xxxxxxxxxx(1-xxxxxx-1X-xxxxxxx-3-xx)-xxxxxxxx |
||
|
XXX-019 |
1-xxxxx-3-(1-xxxxxxx)xxxxx |
||
|
XXX-022 |
xxxxxxxx-1-xx(2-(xxxx-4-xxxx)-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-030 |
xxxxxxxx-1-xx(1-xxxxxx-1X-xxxxxx-3-xx)xxxxxxxx |
||
|
XXX-071 |
(1-xxxxx-1X-xxxxx-3-xx)-1-xxxxxxxxx 1-methanon |
||
|
JWH-073 |
(1-butyl-1H-indol-3-yl)(naftalen-1-yl)methanon |
||
|
JWH-073 xxxxxx xxxxxxx |
1-xxxxx-3-(1-(4-xxxxxx)xxxxxxx)xxxxx) |
||
|
XXX-081 |
(4-xxxxxxxxxxxxxxx-1-xx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-122 |
(4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-122 xxxxxxxx 2-xxxxxxxxxxx xxxxxxx |
(4-xxxxxxxxxxxxxx-1-xx)(2-xxxxxx 1-(pent-4-en-1-yl)-1H-indol-3-yl)methanon |
||
|
JWH-122 xxxxxxxx xxxxxxx |
(4-xxxxxxxxxxxxxx-1-xx)(1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-145 |
xxxxxxxx-1-xx(1-xxxxxx-5-xxxxx-1X-xxxxxx-3-xx)xxxxxxxx |
||
|
XXX-182 |
1-xxxxxx-3-(4-xxxxxx-1-xxxxxxx)xxxxx |
||
|
XXX-200 |
[1-(2-xxxxxxxxxxxxxx)-1X-xxxxx-3-xx] (naftalen-1-yl)methanon |
||
|
JWH-203 |
2-(2-chlorfenyl)-1-(1-pentylindol-3-yl)ethanon |
||
|
JWH-210 |
(4-ethylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon |
||
|
JWH-250 |
2-(2-methoxyfenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-on |
||
|
JWH-2501 2-xxxxxxxx-X-xxxxxx-xxxxxxxxx xxxxxxx |
1-(2-xxxxxxxx-X-xxxxxxxxxxxxxxx)-3-(2-xxxxxxxxxxxxxxxxxx)xxxxx |
||
|
XXX-251 |
2-(2-xxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-302 |
1-xxxxxx-3-(3-xxxxxxxxxxxxxxxxxx)xxxxx |
||
|
XXX-307 |
(5-(2-xxxxxxxxxx)-1-xxxxxxxxxxxx-3-xx)-xxxxxxxx-1-xxxxxxxxxx |
||
|
XXX-307 xxxx xxxxxxx |
(5-(2-xxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-368 |
[5-(3-xxxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx]-1-xxxxxxxxxx-xxxxxxxx |
||
|
XXX-370 |
[5-(2-xxxxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx]-1-xxxxxxxxxx-xxxxxxxx |
||
|
XXX-387 |
1-xxxxxx-3-(4-xxxx-1-xxxxxxx)xxxxx |
||
|
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-412 |
|||
|
XXX-412 5-fluorpentyl derivát |
(4-fluornaftalen-1-yl)[1-(5-fluorpentyl)-1H-indol-3-yl]methanon |
||
|
JWH-methylcyklohexan-8-chinolinol; XX-22 |
xxxxxxxx-8-xx 1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
Xxxxxxxx |
(2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
||
|
Xxxxxxxxxxxxx |
xxxxxxxxxx; BRN 4550445 |
8-xxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxx[4,3-x] [1,4]xxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
6-(2-xxxxxxxxxx)-1-xxxxxx-8-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-(xxxxxxxxxxxxxxxxx)-7-xxxx-1,3-xxxxxxx-2X-[1,4]-xxxxxxxxxxxxx-2-xx |
||
|
XXX-701 |
1-(5-xxxxxxxxxxx)-X-xxxxx-xxxxx-3-xxxxxxxxxx |
||
|
XX2183240 |
X,X-xxxxxxxx-5-[(4-xxxxxxx)xxxxxx]xxxxxxxx-1-xxxxxxxxxx |
||
|
X5XXXX |
xxxxxx-1-(5-xxxxxxxxxxx)-1X-xxxxx-xxxxxxxxxx |
||
|
XXX-2201 |
1-(5-xxxxxxxxxxx)-3-(4-xxxxxx-xxxxxxx)xxxxx |
||
|
XXX-2201 xxxxxxxxxxx xxxxxxx |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](4-xxxxxx-xxxxxxxx-1-xx)-xxxxxxxx |
||
|
XXX-XXXXXXXX |
2-(1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx xxxxxxxx |
||
|
XXXX |
1 -benzyl-4-methylpiperazin |
||
|
MDA 19 |
X-[(X)-(1-xxxxx-2-xxxxxxxx-3-xxxxxx)xxxxx]xxxxxxxx |
||
|
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
|
XXXX-4xx-XXXXXX |
(xxxxxx 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazol-3-karboxamido) xxxxxxxx) |
||
|
XXXX-XXXXXX |
xxxxxx 2-(1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
|
XXXX-XXXXXXXX |
2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3,3-xxxxxxxxxxxxxxxx |
||
|
XXXX-XXXXXXX |
xxxxxx 2-(9-(cyklohexylmethyl)-9H-karbazol-3-karboxamido)-3,3-dimethylbutanoát |
||
|
MDMB-CHMICA |
N-[[1-(cyklohexylmethyl)-1H-indol-3-yl]karbonyl]-3-methyl-valin, xxxxxx xxxxx |
||
|
XXXX-XXXXX |
xxxxxx 3,3-dimethyl-2-(9-pentyl-9 X-xxxxxxxx-3-xxxxxxxxxxx)xxxxxxxx |
||
|
XXXXX; 3,4-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
|
Xxxxxxxxxxxx |
(X)-5-(2-xxxxxxxxxx)-3-xxxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxx |
(4-xxxxxxxxxxxxxxx-1-xx)-(1-xxxxxxxxxxx-3-xx)xxxxxxxx |
||
|
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxx, Xxxxxxxxxxxxxxx |
2-xxxxxxxxxxxxx-1-xxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxxxxx |
xxxxxxxxxxxxxxxxx, |
X-xxxxxx-1-(xxxxxxxx-2-xx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxx |
X-(2-xxxxxxx-xX-xxxxxxxxxxx)-5X,8X,11X,14X-xxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
xx-XXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
|
|
xxxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxxxxx |
2-XxX-xxxxxxxxx |
|
Xxxxxxxxxxxxxx |
XXXx, 2-Xxx-3'-xxxxxxx-XXXx |
2-(3-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-[5-xxxxxxx-3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxx |
(±)-5-xxxxx-4-xxxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxxx |
XX 690; XX-690; xxxxxxxxxxxxxxxx; Ro 05-4082; Ro 5-4082 |
5-(2-chlorfenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-on |
|
|
Methylon |
Bk-MDMA |
2-(methylamino)-1-[3,4-(methylendioxy)fenyl]propan-1-on |
|
|
Methyltenamfetamin |
MDMA |
(2R,S)-N-methyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
|
|
Methylthienylpropamin |
MPA |
N-methyl-1-(thiofen-2-yl)propan-2-amin |
|
|
Metizolam |
Desmethyletizolam |
4-(2-chlorfenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]tnazolo[4,3-a][1,4]diazepin |
|
|
Mexedron |
4-MMC-oMe; XXX |
(3-xxxxxxx-2-(xxxxxxxxxxx)-1-(x-xxxxx)xxxxxx-1-xx |
|
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
|
|
X-XXXXX |
1-(xxxxxxxxxxxxxxxx)-2-xxxxxx-xxxxx-3-xxxxxxxxxx |
||
|
XX-18 |
X-(xxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XX-XXXXXXXX |
1-xxxxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx 1-(cyklohexylmethyl)-1H-indazol-3-karboxylát |
||
|
MPhP-2201 |
methyl 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxxx}-3-xxxxxxxxxxxxxx |
||
|
X-(2-xxxxxxxxxxxx)-X-(1-xxxxxxxxxxx)-2-(1-xxxxxx-1X-xxxxx-3-xx)-4-xxxxxxx-xxxxxxxxxx |
|||
|
X,X-xxxxxxx-2-(1-xxxxxx-1X-xxxxx-3-xx)-4-xxxxxxx-xxxxxxxxxx |
|||
|
Xxxxxxxxxxxxxxxxx |
Xxxxxxx |
1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
X-2482 |
|
X-xxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxxxx, XXX |
2-(xxxxxxxxxx)-1-xxxxxxxxxx-1-xx |
|
|
X-xxxxxxxxxxxxx |
xxxxx-xxxxxxxxx, xxxxxxxxxxxxxx-xxxxxxxxxxxxxxxxxx, XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
XXX-xxxxx xxxxxx |
xx-XXX; , xx-XXXXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx)xxxxx-1-xx |
|
|
X-xxxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-1-xxxxxxxxxx-1-xx |
|
|
X-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxxx-1-xx |
|
|
X-xxxxxxxxxxxxx |
XXX-XX; Xxxxxxxxxxxxxx; Xxxxx-Xxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxx-1-xx |
|
|
X-xxxxx-xxxxxxxxxxx |
XXxX |
2-(xxxxxxxxxx)-4-xxxxxx-1-xxxxxxxxxxx-1-xx |
|
|
X-xxxxxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxxx-1-xx |
α-xxxxxxxxxxxxxxxxxx-xxx |
|
Xxxxxxxxx |
5-(2-xxxxxxxxxx)-3-xxxxxxx-7-xxxxx-1X-xxxxx[x][1,4]xxxxxxxx-2(3X)-xx |
||
|
X-xxxxxxxxxxxxxxxxx |
XxXX; X-xxxxxxxxxxxxxxxxx |
2-(xxxxxxxxxxxxxx)-1-xxxxxxxxxx-1-xx |
|
|
X-xxxxxxxxxxxxxxxxxx |
XxXX; XXX, 2-XXX |
2-(xxxxxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxx |
1-xxxxxx-8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x] [1,4]xxxxxxxxxxxxx |
||
|
XX-2201, XXX-2201 |
xxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
X-xxxxxx-2-xxxxxxxxxx |
X-xxxxxx-2XX |
2,3-xxxxxxx-X-xxxxxx-1X-xxxxx-2-xxxx |
XX-2XX |
|
X-xxxxxxxxxxxxxxx |
2-[xxxxxx(xxxxxx)xxxxx]-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxxxxx, desalkyl-flurazepam, norflurazepam, Xx 5-3367 |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-1,4-xxxxxxxxxxxxx-2-xx |
|
|
X-xxxxxxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
x-Xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx }xxxxxx |
Xxxxxxxxxx |
|
x-Xxxxxxxxxxxxxxxxx |
XXX |
3-{-2-[(xxxxxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxxxxxxxx}xxxxx |
|
|
Xxx 27569 |
5-xxxxx-3-xxxxx-X-{2-[4-(1-xxxxxxxxxxx)xxxxx]xxxxx}-1X-xxxxx-2-xxxxxxxxxx |
||
|
Xxx 27759 |
5-xxxxx-3-xxxxx-X-{2-[4-(xxxxxxxxxxxxx)xxxxx]xxxxx}-1X-xxxxx-2-xxxxxxxxxx |
||
|
Xxx 29647 |
5-chlor-3-ethyl-N-(1-benzylpyrrolidin-3-yl)-3H-indol-2-karboxamid |
||
|
Parahexyl |
3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol |
||
|
PB-22 xxxxxxx analog |
chinolin-8-yl-1-pentyl-1H-indazol-3-karboxylát |
||
|
Pentedron |
1-fenyl-2-(methylamino)pentan-1-on |
||
|
Pentylon |
Methylendioxypentedron; βx-XXXX |
(±)-1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
|
|
x-Xxxxxx-4-xxxxxxxxxxxxxx |
4,4'-XXXX |
4-xxxxxx-5-(4-xxxxxxxxxxx)-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
x4-XXXX |
|
Xxxxxxxxxx |
XXX 48,098 |
(4-xxxxxxxxxxxx)-[2-xxxxxx-1-(2-xxxxxxxx-4-xxxxxxx)xxxxx-3-xx]xxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxx; XX |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxx |
X-xxxxxxxxxxxxxxxxxx; |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxxxxxxxx |
||
|
XX8, α-XXXX |
1 -xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
|
XX9, α-XXX |
1 -fenyl-2-(pyrrolidin-1-yl)-1-oktan-1-on |
||
|
Pyrazolam |
8-brom-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3 -x] [1,4]xxxxxxxxxxxxx |
||
|
XXX-4 |
(4-xxxxxxxxxxxx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-4 xxxxx xxxxxx |
(2-xxxxxxxxxxxx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-4(X4) |
4-xxxxxxxxxxx1-(1-xxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
Xxxxxxxxxxxx |
XXX, XXXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxxx |
|
|
Xxxxxxxxxx X |
xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x,10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxxx[x] isochromen-7-karboxylát |
||
|
SDB-005 |
naftalen-1-yl-1-pentyl-1H-indazol-3-karboxylát |
||
|
SDB-006 |
N-benzyl-1-pentyl-1H-indol-3-karboxamid |
||
|
SDB-006 X-xxxxx xxxxxx |
1-xxxxxx-X-xxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXX-135 |
X-(1-xxxxxxxxx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
Xxxxxxxxxxxx |
XXX |
(2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
|
Xxxxxxxx |
xXxXXX; XXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxx-xxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
Δ6x(10x)-, Δ6α(7)-, Δ7-, Δ8-, Δ10-, Δ9(11)-tetrahydrokanabinoly x xxxxxx xxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xxxxx |
||
|
XXX-2201 |
5X-XXX-018-X, |
[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx] (1 -nařryl)methanon |
|
|
TH-PBP; 3',4'-xxxxxxxxxxxxxx-α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxx-2-xx)xxxxx-1-xx |
||
|
XX-XXX; 2-pyrrohdin-1-yl-1-tetralin-6-yl- xxxxx-1-xx |
2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxxx-2-xx)xxxxx-1-xx |
||
|
XX-XXX |
2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxxx-2-xx)xxxxxx-1-xx |
||
|
xxxxx-XX 47,497-X8 |
5-(1,1-xxxxxxxxxxxxx)-2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-xxxxx |
||
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
XX-144(-2X); |
[1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xx](2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXXX-018 |
|
|
XX-144xxxxxx xxxxxxx |
(1-xxxxxx-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)-xxxxxxxx |
||
|
XX-144X-(5-xxxxxxxxxxx) xxxxxxx |
(1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
XXX-597 |
[3-(3-xxxxxxxxxxxxxx)xxxxx]-X-xxxxxxxxxxxxxxxxxx |
||
|
XXX-754 |
6-xxxxxx-2-[(4-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxx-4-xx |
||
|
X-15 |
4-xxxxx-X-(1-xxxxxxxxxxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
||
|
X-18 |
4-xxxxx-X-(1-[2-(4-xxxxxxxxxx)xxxxx]-xxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
||
|
XXX 55212-2 |
(R)-(+)-[2,3-dihydro-5-methyl-3-(4-morfolinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yljnaftalen-1-ylmethanon |
||
|
α-PVP |
1-fenyl-2-(pyrrolidin-1-yl)-1-pentan-1-on |
||
|
α-PVT |
2-(pyrrolidin-1-yl)-1-(thiofen-2-yl)pentan-1-on |
||
|
α-Pyrrolidinohexanofenon |
α-PHP |
1-fenyl-2-(pyrrolidin-1-yl)-1-hexan-1-on |
|
|
α-Pyrrolidinoisohexanofenon |
α-ΡιΗΡ |
1-fenyl-4-methyl-2-(pyrrolidin-1-yl)-1-pentan-1-on |
|
|
α-Piperidinbutiofenon |
α-PipBP |
1-fenyl-2-(piperidin-1-yl)butan-1-on |
|
|
α-Pyrrolidinbutiofenon |
α-PBP |
1-fenyl-2-(pyrrolidin-1-yl)butan-1-on |
|
|
α-Pyrrolidinbutiothiofenon |
α-PBT |
2-(pyrrolidin-1-yl)-1-(thiofen-2-yl)butan-1-on |
|
|
α-Pyrrolidinnonafenon |
α-PNP; XX-10; alpha-pyrrolidi-nononaphenone |
1-fenyl-2-(pyrrolidin-1-yl)nonan-1-on |
|
|
α-Pyrrolidinpropiofenon |
α-PPP |
1-fenyl-2-(pyrrolidin-1-yl)propan-1-on |
|
|
β-Keto-indanylmethylaminopropan |
bk-IMP |
1-(2,3-dihydro-1H-inden-5-yl)-2-(methylamino)propan-1-on |
Včetně xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxx, xx xx xxxxxxxx xxxxxxx, xxxxxxxxx v tomto xxxxxxx ve všech xxxxxxxxx, xxx xxxx xxxxxxxxxxxxx xxxxx xxxxxxxxx xxxxx zvláštního xxxxxxxxxx xxxxxxxx a xxxx xxxxxxxxxxxxxx látek uvedených x xxxxx xxxxxxx xx všech případech, xxx xxxxx xxxxxxxxx..
Příloha č. 5 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 5 psychotropních xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx mezinárodní xxxxxxxxxx xxxxx xxxx obecný xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 7-[(10,11-xxxxxxx-5X-xxxxxxx[x,x][7]xxxxxxx-5-xx) xxxxx]xxxxxxxxx |
||
|
Xxxxxxxxxx |
(2X)-2-[(5X,6X,7X,14X)-17-(xxxxxxxxxxxxxxxxx)-4,5α-xxxxx-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx xxxxx-2-xx |
||
|
Xxxxxxxxxxxxxxxxxxxxx amin |
2C-B |
(4-brom-2,5-dimethoxyfenethyl)amin |
|
|
Dexamfetamin |
(2S)-1-fenylpropan-2-amin |
||
|
Fencyklidin |
PCP |
1-(1-fenylcyklohexyl)piperidin |
|
|
Fenetylin |
7-(2-{[(2RS)-1-fenylpropan-2-yl]amino}ethyl)-1,3-dimethyl-7H- xxxxx-2,6-xxxx |
||
|
Xxxxxxxxxxx |
2-xxxxX-3-xxxxxxxxxxxxxx |
||
| Xxxxxxxxx | 1-xxxxx-2-xxxxxxxxx-xxx-2-xxxx | ||
|
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx |
||
|
XXX |
xxxxxxxx 4-xxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxx |
(2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
| Xxxxxxxxxxxxxxx | (2X)-2,6-xxxxxxx-X-[(2X)-1-xxxxxxxxxxx-2-xx]xxxxxxxxx | ||
|
Xxxxxxxxxxx |
3-(2-xxxxxxxxxx)-2-xxxxxx-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
|
Xxxxxxxxxx |
2-xxxxxxx-3-(2-xxxxxxxxxxx)-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
|
Xxxxxxxxxxxx |
(2X)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxx xxxxxxxxx |
(2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxx |
xxxxxx-(2XX)-2-xxxxx-2-[(2XX)-xxxxxxxxx-2-xx]xxxxxx |
||
|
Xxxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxx-9-XXX |
Δ9-xxxxxxxxxxxxxxxxxxx (XXX) x xxxx xxxxxxxxxxxxx |
xxxx. (-)-trans-Δ9-THC |
|
Zipeprol |
(2RS)-1-fenyl-1-methoxy-3-[4-(2-methoxyfenethyl)piperazin-1-yl] xxxxxx-2xx |
Xxxxxx xxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx xxxxxxxxx, kdy existence xxxxxxxx xxxx xx xxxxx.
Xxxxxxx x. 6 x xxxxxxxx xxxxx x. 463/2013 Sb.
Seznam x. 6 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v xxxxxx xxxxxx |
Xxxxx mezinárodní nechráněný xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxx |
xxxxxxxx 5-ethyl-5-isopentylbarbiturová |
||
|
Butalbital |
kyselina 5-xxxxx-5-xxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
xxxxxxxx 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx |
||
|
Xxxxxx |
(+)-xxxxxxxxxxxxxxxx |
(1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxxx |
(2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- xxxxxxxxx-2,6-xxxxxxx-3-xxxxxxxxxx-8-xx |
||
|
Xxxxxxxxxxxxx |
xxxxxxxx 5-ethyl-5[(1RS)-1-methylbutyl]barbiturorá |
Včetně xxxx látek uvedených x této skupině xx xxxxx xxxxxxxxx, xxx existence xxxxxxxx xxxx xx možná.
Xxxxxxx x. 7 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 7 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx nechráněný xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxx |
8-xxxxx-6-xxxxx-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
2-(xxxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
||
|
Xxxxxxxx |
5-xxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx kyselina |
||
|
Bentazepam |
CI 718; XX 6008; Xxxxxxxxxx; |
5-xxxxx-1,3,6,7,8,9-xxxxxxxxx-2X-[1]xxxxxxxxxxx[2,3-x] [1,4]xxxxxxxx-2-xx |
|
|
Xxxxxxxxxxx |
(+)-X-xxxxxx-X-(2-xxxxx-1-xxxxxxxxxx)-X-xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
1-xxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
7-xxxx-5-(2-xxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
2-xxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-ƒ][1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxx |
||
|
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxx |
XX-798; |
4-[[7-xxxx-5-(2-xxxxxxxxxx)-2-xxx-1,3-xxxxxxx-1,4-xxxxxxxxxxxxx-3-xx]xxx]-4-xxx-xxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxx |
8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxxxxxxx |
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx |
||
|
Xxxxxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxx |
||
|
Xxxxxxxxx |
7-Xxxxx-5-(2-xxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxxxx |
(2X,3X)-2-xxxxx-3,4-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-3-xxxxxxxxxxxx[2.2.1]xxxxxx |
||
|
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx kyselina |
||
|
Fenproporex |
(+)-1-fenyl-2-[(2-kyanethyl)amino] xxxxxx |
||
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-2-[2-(xxxxxxxxxxxx)xxxxx]-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
XX-xxxxxx |
7-xxxxx-5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
XX-xxxxxxxx |
10-xxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-2-(xxxxxxxxxxx)-3X-1,4-xxxxxxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2-xxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-3-xx-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxx |
(2XX)-2-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
11-xxxxx-12x-xxxxx-2,8-xxxxxxxx-8,12x-xxxxxxx-4X-[1,3]xxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-4,7(6X)-xxxx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1X-1,5-xxxxxxxxxxxxx-2,4(3X,5X)-xxxx |
||
|
Xxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxxxx |
XXX |
(-)-1-(xxxxxxxxxxxxx)-1,2-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
6-(2-xxxxxxxxxx)-2-[(4-xxxxxxxxxxxxxxx-1-xx)xxxxxx]-8-xxxxx-2,4-xxxxxxx-1X-xxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
5-(4-xxxxxxxxxx)-2,5-xxxxxxx-3X-xxxxxxx[2.1-α]-xxxxxxxx-5-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
(±)-2-[(3-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
2-xxxxxx-2-xxxxxxxxxxxx-1,3-xxxx-xxxxxxxxxx |
||
|
Xxxxxxxx |
X-(xxxxxxxxxxxxxx)-3-(2-xxxxx-1-xxxxxxxxxxx)xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxx |
5-xxxxx-5-xxxxx-1-xxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
3,3-xxxxxxx-5-xxxxxxxxxxxxxxx-2,4-xxxx |
||
|
Xxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-xxxxxxx[1,5-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
5-xxxxx-1-xxxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
5-xxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
10-xxxxx-11x-xxxxx-2-xxxxxx-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x] [1,4]benzodiazepin-6(5H)-on |
||
|
Pemolin |
5-fenyl-2-imino-1,3-oxazolidin-4-on |
||
|
Pinazepam |
7-chlor-5-fenyl-1-(prop-2-yn-1-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Pipradrol |
difenyl(2-piperidyl)methanol |
||
|
Prazepam |
7-chlor-1-(cyklopropylmethyl)-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Pyrovaleron |
(+)-1-(4-methylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
||
|
Sekbutabarbital |
5-ethyl-5-(1-methylpropyl)barbiturová xxxxxxxx |
||
|
Xxxxxxxxx |
(XX)-7-xxxxx-5-xxxxx-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-(xxxxxxxx-1-xx-1-xx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
| Xxxxxxxxx | Xxxxxxxxx, Emandaxin, XXXX 341 Xxxxxxxxx, Seriel, XX | 1-(3,4-xxxxxxxxxxxxxx)-5-xxxxx-7,8-xxxxxxxxx-4-xxxxxx-5X-2,3-xxxxxxxxxxxxx | |
|
Xxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
5-(1-xxxxxxxxxxx)-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxx |
X,X,6-xxxxxxxxx-2-(4-xxxxxxxxxxx)xxxxxxx[1,2-x]xxxxxxx-3-xxxxxxxx |
Xxxxxx xxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxx x&xxxx;xxxxx xxxxxxx ve xxxxx xxxxxxxxx, kdy xxxx xxxx xxxxx xxxxxxxxx.
Xxxxxxx x. 8 x xxxxxxxx vlády x. 463/2013 Sb.
Seznam x. 8 xxxxxxxxx xxxxxxxxx
|
Xxxxxxxxx xxxxxxxxxx: |
Xxxxxxxx: |
||
|
1) |
xxxxx x xxxxxxxx látek: acetyldihydrokodein dihydrokodein ethyImorfin folkodin kodein nikodikodin nikokodin norkodein |
Mohou xxxxxxxxx xxxxx nebo xxxx xxxxxxx xxxxx (xxxxxxx xxxx xxxxxxxx) a xxxxxxxx omamné látky |
|
|
a) |
v xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x jiné lékové xxxxx nesmí xxxxxxxxxx 100 xx, |
||
|
x) |
x roztoku xxxxx xxx koncentrace xxxxx xxx 2,5 % |
||
|
2) |
xxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxx xxxxx xxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, ampuli, xxxxx, příp. v xxxx xxxxxx xxxxx 0,5 xx. |
|
x) |
Xxxxxxxx atropin-sulfátu xxxx xxx nejméně 5 % k xxxxxxxx xxxxxxxxxxxx x xxxxx xxxxxxx, kapsli, xxxxxx, xxxxx, popř. xxxx xxxxxx xxxxx. |
||
|
3) |
xxxxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxxxx xxxxx xxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x jiné xxxxxx xxxxx 2,5 xx. |
|
x) |
Xxxxxxxx atropin-sulfátu xxxx xxx xxxxxxx 1 % x množství xxxxxxxxxxxx v xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, popř. v xxxx xxxxxx xxxxx. |
||
|
4) |
xxxxxxxxxxxxxxxx |
Xxxxxxxx xxxxxxxxxxxxxxxxx |
|
|
x) |
xxxxx xxxxxxxxxx 135 xx x xxxxx xxxxxxx, tobolce, ampuli, xxxxx, xxxx. v xxxx xxxxxx formě. |
||
|
b) |
v xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxx xxx 2,5 %. |
||
|
Xxxxxxxxx xxxxx xxxxxxxxx žádnou xxxxxxxxxxxx xxxxx. |
|||
|
5) |
xxxxxx |
Xxxxxxxx xxxxxxx xxxxx xxxxxxxxxx 0,1 % xxxxxxx. |
|
|
6) |
xxxxx xxxx xxxxxx |
x) |
Xxxxxxxx xxxxxxx xxxxx xxxxxxxxxx 0,2 %. |
|
b) |
Dále xxxxx xxxxxxxxx jednu nebo xxxx xxxxxxx xxxxx (xxxxxxx xxxx xxxxxxxx). |
||
|
Xxxxxx xxxxx x xxxxxxxxx xxxxxxxx xxxxx xxx xxxxxx xxxxxxx xxxx x xxxxxxx xxxxxxxx, xxx xxxxxxxx veřejné xxxxxx |
|||
|
7) |
xxxxxxxxxxxxx prášek x xxxxx |
x) |
Xxxxxxxx xxxx x xxxxxx nesmí xxx xxxxx xxx 10 %. |
|
x) |
Xxxxxxxx xxxxxxxxxxxxxxx xxxxxx xxxxx xxx xxxxx xxx 10 %. |
||
|
x} |
Xxxxxxxx xxxxx xxxx více xxxxxxx xxxxx (xxxxxxx xxxx ornamných) xxxxx xxx nižší xxx 80%. |
||
|
8) |
xxxxxxxxx |
x) |
Xxxxxxxxx propiramu xxxxx xxxxxxxxxx 100 xx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x jiné Xxxxxx xxxxx. |
|
x) |
Xxxxxxxxx xxxxxxxxxxxxxx x xxxxxxxxx musí xxx xxxxxxx stejné xxxx xxxxx než xxxxxxxxx. |
||
Xxxxxx xxxxxxxxxxxx vyrobených xxxxxxxxx, xxxxxxx stupeň xxxxxx je xxxxx xxx X4 xxxx XX2.
Xx. II
Toto xxxxxxxx xxxx oznámeno x xxxxxxx xx směrnicí Xxxxxxxxxx xxxxxxxxxx x Xxxx (EU) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx při xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx pro xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. II xxxxxx právním xxxxxxxxx x. 46/2017 Sb. x účinností xx 1.3.2017
Čl. II
Toto xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 xx dne 9. xxxx 2015 o xxxxxxx při poskytování xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx xxxxxxxxx x. 30/2018 Xx. x xxxxxxxxx xx 8.3.2018
Čl. II
Toto xxxxxxxx xxxx oznámeno x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 o xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx předpisů a xxxxxxxx xxx služby xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx právním xxxxxxxxx x. 242/2018 Xx. x xxxxxxxxx xx 25.10.2018
Xx. XX
Xxxxxxxxx xxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx se xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (EU) 2015/1535 ze xxx 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx informační xxxxxxxxxxx.
Xx. XX xxxxxx právním xxxxxxxxx x. 184/2021 Xx. x xxxxxxxxx xx 3.6.2021
Čl. II
Technický předpis
Toto xxxxxxxx xxxx oznámeno x xxxxxxx xx xxxxxxxx Evropského xxxxxxxxxx x Rady (XX) 2015/1535 ze xxx 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx předpisů x xxxxxxxx xxx xxxxxx informační xxxxxxxxxxx.
Xx. XX xxxxxx právním xxxxxxxxx x. 159/2022 Xx. x xxxxxxxxx xx 1.7.2022
Xx. XX
Xxxxxxxxx xxxxxxx
Xxxx xxxxxxxx bylo oznámeno x xxxxxxx se xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 ze xxx 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx informací x xxxxxxx xxxxxxxxxxx předpisů x xxxxxxxx xxx xxxxxx informační xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx xxxxxxxxx x. 228/2023 Xx. x xxxxxxxxx xx 1.8.2023
Xxxxxx předpis č. 463/2013 Xx. xxxxx xxxxxxxxx xxxx 1.1.2014.
Xx xxxxx xxxxxx xxxxxxxx xxxxxxxx xxxx podchyceny xxxxx a doplnění xxxxxxxxxxx právním předpisem x.:
243/2015 Sb., xxxxxx xx xxxx nařízení xxxxx č. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx
x xxxxxxxxx xx 1.10.2015
46/2017 Xx., xxxxxx se xxxx xxxxxxxx xxxxx č. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx znění nařízení xxxxx x. 243/2015 Xx.
x xxxxxxxxx od 1.3.2017 s výjimkou xxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxxx xxxxxxxxx 1.5.2017
30/2018 Xx., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Sb., x seznamech xxxxxxxxxx xxxxx, ve xxxxx xxxxxxxxxx předpisů
s účinností xx 8.3.2018
242/2018 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx od 25.10.2018
184/2021 Xx., xxxxxx xx mění xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx látek, ve xxxxx xxxxxxxxxx předpisů
s xxxxxxxxx xx 3.6.2021
159/2022 Xx., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Xx., x seznamech návykových xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.7.2022
228/2023 Sb., xxxxxx se xxxx xxxxxxxx xxxxx x. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx látek, xx xxxxx pozdějších xxxxxxxx
x xxxxxxxxx xx 1.8.2023
52/2024 Xx., kterým xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 6.3.2024 x 1.1.2025
176/2023 Xx., xxxxxx xx xxxx xxxxxxxx vlády x. 463/2013 Sb., o xxxxxxxxx návykových látek, xx xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 1.7.2024 x 1.1.2025
419/2024 Xx., xxxxxx se xxxx nařízení xxxxx x. 463/2013 Sb., x seznamech xxxxxxxxxx xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x účinností xx 1.1.2025 x 1.4.2025
534/2025 Sb., kterým xx xxxx nařízení vlády x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, x xxxxxxxx xxxxx x. 11/2025 Xx., x xxxxxxx xxxxxxxxxx psychoaktivních xxxxx
x účinností od 16.12.2025 x výjimkou xxxxxxx x. 5, xxxxx xxxxxx xxxxxxxxx 1.1.2026
Xxxxx xxxxxxxxxxxx právních xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.
1) Jednotná xxxxxx x xxxxxxxx xxxxxxx, xxxxxxxxx pod č. 47/1965 Sb., xx xxxxx Xxxxxxxxx x xxxxxxx Xxxxxxxx xxxxxx x omamných xxxxxxx, xxxxxxxxxxx pod č. 458/1991 Sb.
Xxxxxxxx Komise x xxxxxxxxx pravomoci (EU) 2022/1326 ze dne 18. xxxxxx 2022, xxxxxx xx xxxx xxxxxxx rámcového xxxxxxxxxx Xxxx 2004/757/XXX, pokud xxx x zahrnutí xxxxxx xxxxxxxxxxxxxxx xxxxx xx xxxxxxxx drogy.
2) Úmluva x xxxxxxxxxxxxxx xxxxxxx, xxxxxxxxx xxx č. 62/1989 Sb.
3) Rámcové rozhodnutí Xxxx 2004/757/XXX xx xxx 25. xxxxx 2004, xxxxxx se xxxxxxx xxxxxxxxx ustanovení xxxxxxxx xx xxxxx xxxxxxxxxx xxxxxxx xxxxxxxxx xxxx x xxxxxx x oblasti xxxxxxxxxxxx xxxxxxx x xxxxxxx.
Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx (XX) 2017/2103 xx dne 15. xxxxxxxxx 2017, xxxxxx xx xxxx xxxxxxx xxxxxxxxxx Rady 2004/757/XXX x cílem xxxxxxxx xx definice drogy xxxx xxxxxxxxxxxxx xxxxx x xxxxxxx xxxxxxxxxx Xxxx 2005/387/XXX.
Xxxxxxxx Komise x xxxxxxxxx xxxxxxxxx (XX) 2019/369 ze xxx 13. prosince 2018, kterou xx xxxx xxxxxxx xxxxxxxxx xxxxxxxxxx Xxxx 2004/757/SVV, xxxxx xxx o xxxxxxxx nových xxxxxxxxxxxxxxx xxxxx xx xxxxxxxx xxxxx.
Xxxxxxxx Xxxxxx x xxxxxxxxx pravomoci (XX) 2020/1687 xx dne 2. xxxx 2020, xxxxxx xx mění xxxxxxx rámcového xxxxxxxxxx Xxxx 2004/757/SVV, pokud xxx x xxxxxxxx xxxx xxxxxxxxxxxxx xxxxx X,X-xxxxxxx-2-[[4-(1-xxxxxxxxxxxx)xxxxx]xxxxxx]-5-xxxxx-1 H-benzimidazol-1-ethanamin (xxxxxxxxxxxx) xx xxxxxxxx drogy.
Směrnice Xxxxxx v xxxxxxxxx xxxxxxxxx (EU) 2021/802 xx dne 12. xxxxxx 2021, kterou xx mění příloha xxxxxxxxx rozhodnutí Xxxx 2004/757/XXX, xxxxx jde x xxxxxxxx xxxxxx xxxxxxxxxxxxxxx xxxxx methyl 3,3-xxxxxxxx-2-{[1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx} butanoát (XXXX-4xx-XXXXXX) x xxxxxx 2-{[1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx (4X-XXXX-XXXX) do xxxxxxxx xxxxx.